Gene Query: COPG2

Dataset Description Geneva Score
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 47.99
HNRNPL and its RNA Targets in Prostate Cancer 47.99
Genome wide expression change by RNF168 knocking down in MCF-7 cells 26.08
RNAseq of HEK293 cells after Chtop knockdown 24.63
Co-transcriptional loading of RNA export factors shapes the human transcriptome 24.63
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 21.97
Crizotinib v. DMSO in SW480 cells 19.1
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 17.98
Global expression profiles in cardiac progenitor cells generated by ISX-9 17.47
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 17.47
Genome-wide analysis of STAT3 in diffuse large B-cell lymphoma 17.33
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 16.61
Zika infected neural stem cells 16.29
Transcriptome analysis of Zika infected neural stem cells 16.29
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 15.7
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 15.59
Activating PAX Gene Family Paralogs to Complement PAX5 Leukemia Driver Mutations 14.88
LIN28A modulates splicing and gene expression programs in breast cancer cells 14.88
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 14.88
Effect of CHKA knockdown on C4-2 cell transcriptome 14.87
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 14.59
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 14.19
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 13.21
microRNA-seq and RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 12.78
RNA-seq reveals changes in the astrocyte transcriptome following Borrelia burgdorferi infection 12.78
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 12.54
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 11.83
RNA-seq analysis of AML cells in response to ASLAN003 11.76
TT-Seq captures the human transient transcriptome 11.69
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 11.65
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 11.65
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 11.65
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 11.46
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 11.08
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 10.42
Differential gene expression profiles in imatinib-resistant cell lines 10.27
The effect of PPARG inhibition on human angiomyolipoma cells 10.21
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells 10.18
Gata6 potently initiates reprogramming of pluripotent and differentiated cells to extraembryonic endoderm stem cells [ChIP-Seq & RNA-Seq] 10.18
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 10.18
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 10.17
MeRIP-seq for heat shock in B-cell lymphoma cells 10.06
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 9.95
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 9.88
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 9.57
Changes in RNA expression in human oral cavity carcinoma cells as a result of LDB1 reduction 9.35
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 9.33
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 9.33
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 9.29
Genome wide expression change in LCC2 and MCF-7 cells 9.29
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 9.23
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 9.12
DART-seq: an antibody-free method for global m6A detection 9.07
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 8.9
N6-methyladenine DNA Modification in Glioblastoma 8.9
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 8.83
RNA-seq of YB5 and MCF7 treated with different doses of decitabine 8.77
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.67
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 8.62
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 8.57
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 8.57
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 8.53
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 8.53
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 8.34
Genome wide expression change by RNF168 knocking down in NEC cells 8.31
Role of CD133 molecule in WNT response and renal repair 8.17
A sister of NANOG regulates genes expressed in pre-implantation human development 8.13
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 8.13
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 8.1
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 8.08
Silencing p300 in MCF7 cells to study expression and alternative splicing 8.06
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 7.94
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 7.91
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 7.91
RIG-I and MDA5 fRIP during KSHV lytic reactivation 7.9
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 7.84
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 7.78
Molecular Criteria for Defining the Naive Human Pluripotent State 7.76
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 7.66
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 7.54
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 7.54
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 7.53
Oncogenic MYC induces a dependency on the spliceosome in human cancer 7.53
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 7.51
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 7.47
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 7.45
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 7.45
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 7.32
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 7.3
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 7.28
Region-specific Innate Antiviral Responses of the Human Epididymis 7.26
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 7.24
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 7.23
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 7.19
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 7.16
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 7.12
Identification of global regulators of T-helper cell lineage specification 7.12
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 7.08
Patient-derived luminal breast cancer xenografts with progestins 7.08
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 7.08
Global analysis of alternative splicing regulated by RBM10 6.93
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 6.93
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 6.93
BAF controls genome accessibility 6.91
RNA-seq of naive and primed ES cells 6.83
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 6.82
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.76
RNA-seq in transgenic cells 6.75
DIGIT regulates endoderm differentiation of human embryonic stem cells 6.74
Differentially expressed vascular development genes for iPSC-ECs from CDI 6.74
RNA-seq analysis of uveal melanoma cells treated with FR900359 6.73
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 6.68
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 6.66
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 6.63
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 6.63
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 6.59
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 6.59
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 6.58
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 6.57
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 6.57
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 6.55
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 6.55
IDH3a KO RNA-seq 6.53
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.52
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-Seq] 6.51
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 6.5
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 6.5
Rational targeting of RNA structure in SMN2 transcripts reverses Spinal Muscular Atrophy molecular phenotypes 6.5
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 6.44
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 6.44
HNF1A deficiency impairs β-cell fate, granule maturation and function 6.43
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 6.41
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 6.32
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 6.32
Antiviral innate immunity of hepatitis C virus-infected stem cell-derived hepatocytes 6.29
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 6.29
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 6.29
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 6.27
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 6.27
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.25
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 6.17
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 6.15
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.12
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.12
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 6.12
Characterization and transplantation of enteric neural crest cells from human induced pluripotent stem cells 6.07
Cerebellar differentiation in Ataxia-Telangiectasia 6.06
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 6.05
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 6.03
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.02
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 5.94
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 5.93
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.92
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 5.88
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.87
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 5.86
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 5.83
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 5.82
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 5.77
AMPK signaling for naïve pluripotency [Hs] 5.73
AMPK signaling for naïve pluripotency 5.73
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 5.73
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 5.73
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 5.72
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 5.68
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 5.59
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 5.55
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 5.51
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.46
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.46
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 5.46
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.45
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 5.45
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.45
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 5.45
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 5.45
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 5.44
Molecular Signatures Associated with ZIKV Exposure in Human Cortical Neural Progenitors 5.42
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 5.4
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 5.4
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 5.36
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 5.32
5.3
Transcriptomic of MKD (MUC1 kidney disease) patient compares to normal derived kidney epithelial cells 5.28
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 5.25
Next Generation Sequencing of control (Untreated), PAN injured and Adriamycin injured human podocytes 5.2
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 5.2
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 5.19
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 5.16
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 5.13
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 5.11
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 5.11
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 5.09
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 5.09
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 5.08
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 5.08
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 5.08
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 5.07
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.06
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 5.0
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 4.99
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 4.98
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 4.98
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 4.97
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 4.97
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 4.96
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 4.95
RNA-Seq from early time points in the kidney differentiation protocol 4.93
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 4.9
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 4.9
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 4.87
UBC9 knockdown in bladder cancer T24 cell lines 4.86
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 4.86
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 4.84
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 4.83
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 4.82
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 4.82
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.8
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.8
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 4.8
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 4.78
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 4.77
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.74
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma 4.72
Targeted degradation of BRD9 reverses oncogenic gene expression in synovial sarcoma [RNA-seq] 4.72
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 4.71
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 4.7
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 4.7
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 4.69
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 4.69
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 4.66
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 4.66
Genome-wide chromatin analysis of Ewing sarcoma 4.65
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 4.65
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 4.63
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 4.62
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.6
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 4.56
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 4.56
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 4.56
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 4.55
Downregulation of DDX5/DDX17 and REST 4.54
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.53
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 4.52
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.52
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 4.52
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.5
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 4.5
Transcriptome analysis of H9 hESC derived cerebral organoids 4.5
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 4.5
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 4.48
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.47
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq Human] 4.42
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.41
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.41
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 4.38
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 4.34
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 4.34
Generation, transcriptome profiling, and functional validation of cone-enriched human retinal organoids 4.32
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 4.31
4.31
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 4.3
WRN knockout effects upon gene expression in SW48 and OVK18 4.28
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 4.23
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 4.23
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 4.2
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 4.19
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 4.16
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 4.15
Global transcriptome analysis of HAP1 cells 4.08
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 4.06
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 4.05
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 4.02
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 4.02
Induced DNA demethylation, genome instability and transcription 4.02
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.02
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 4.01
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 4.0
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 3.98
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 3.98
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 3.98
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 3.97
SETBP1-WT and SETBP1-G870S epigenetic landscapes 3.97
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.93
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.93
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.93
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 3.9
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 3.9
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 3.89
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 3.88
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 3.88
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 3.88
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 3.87
Stage-specific regulation of the WNT/β-catenin pathway enhances differentiation of hESCs into hepatocytes 3.87
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 3.86
Effect of PRDM11 depletion in U2932 cells 3.83
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 3.82
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 3.82
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.81
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 3.79
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.76
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 3.75
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.73
Total RNA sequencing of APC mutant and wt colonic organoids 3.71
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 3.7
KSDM1b Role in Ewing Sarcoma 3.65
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 3.64
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 3.64
MCF-7 as a model for functional analysis of breast cancer risk variants 3.59
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 3.57
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.56
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 3.55
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 3.48
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 3.48
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.47
Biased Expression of the FOXP3Δ3 Isoform in Aggressive Bladder Cancer Mediates Differentiation and Cisplatin Chemotherapy Resistance 3.46
Endometrial transcriptome and PGR cistrome in cycling fertile women 3.43
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 3.43
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 3.42
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 3.42
SLIGRL-induced gene expression changes in NHEK cells 3.42
Human cell line and subcutaneous tumor 3.39
mRNA expression data from ESCs derived by polar body transfer reconstructed embryos (PBTESCs) 3.37
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 3.37
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 3.32
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 3.31
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.3
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 3.3
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 3.3
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.28
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 3.27
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 3.27
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 3.26
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 3.24
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.22
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.22
Characterization of Type I Interferon pathway during Hepatic Differentiation of Human Pluripotent Stem Cells and hepatitis C virus infection 3.19
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.19
NSD2 overexpression links drives clustered chromatin and transcriptional changes in a subset of insulated domains of insulated domains 3.18
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.17
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.17
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 3.13
Human-specific gene ARHGAP11B promotes basal progenitor amplification and neocortex expansion 3.12
RNAseq Study in CC-671 Treated Cal-51 Cells 3.12
LINE-2 transposable elements are a source of functional human microRNAs and target sites 3.12
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 3.05
Expression of MERTK based on Multiple Sclerosis (MS) risk haplotype 3.04
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 3.03
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.02
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 3.02
Functional significance of the HIV-1 Tat signature amino acid residues 3.0
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.0
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.99
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 2.96
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 2.95
mRNA expression in human DAOY cells 2.94
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 2.91
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 2.9
Identification of gene signature in ascitic fluid-isolated mesothelial cells from high grade serous ovarian cancer patients 2.89
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 2.89
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 2.86
Epigenomic conservation of transposable element silencing [RNA-seq] 2.84
Epigenomic conservation of transposable element silencing 2.84
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.79
Global gene expression profile of human peripheral blood-derived endothelial colony-forming cells is similar to coronary artery and umbilical vein endothelial cells 2.69
m6A-dependent regulation of messenger RNA stability 2.69
Controlling for gene expression changes in transcription factor protein networks. 2.68
K562 polyA RNA-Seq 2.63
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.62
Ro60-knockout cells 2.56
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 2.55
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 2.55
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 2.54
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.5
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 2.46
Reciprocal Reprogramming of Cancer Cells and Associated Mesenchymal Stem Cells in Gastric Cancer. 2.4
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 2.4
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.4
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 2.39
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 2.36
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 2.35
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 2.34
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 2.32
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 2.28
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 2.27
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 2.24
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 2.21
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.21
Genome-wide discovery of human splicing branchpoints [RNAse] 2.2
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 2.2
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.19
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.19
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 2.17
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 2.17
RNAseq in Alzheimer's Disease patients 2.16
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.15
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 2.12
High throughput analysis of three human adipose cell lines PAZ6, SGBS and SW872 2.12
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 2.1
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.1
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 1.97
TAF1 is critical for AE driven leukemogenesis 1.97
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.95
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 1.93
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 1.91
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 1.89
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 1.89
Identification of mesothelial-to-mesenchymal gene signature in ascitic fluid-isolated mesothelial cells through RNA-sequencing 1.88
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.88
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.88
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.87
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 1.7
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 1.68
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 1.67
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 1.66
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.66
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.65
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 1.63
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 1.53
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.52
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.52
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 1.5
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.47
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 1.46
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.44
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 1.44
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 1.39
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 1.37
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.33
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 1.31
Deletions in the ATAD3 gene cluster cause cerebellar developmental defects with mitochondrial DNA abnormalities owing to local cholesterol insufficiency 1.28
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.26
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.21
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.21
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.21
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.2
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.19
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.11
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 1.09
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 1.09
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 1.09
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 1.07
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.04
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.04
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.0
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 0.99
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.94
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 0.89
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.81
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.8
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.8
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.69
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.69
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.69
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.68
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.68
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.6
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.58
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.57
HIV Reprograms Human Airway Basal Stem/Progenitor Cells to Acquire a Tissue Destructive Phenotype 0.55
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.54
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 0.52
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 0.52
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 0.51
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 0.51
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 0.51
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules 0.49
Conversion of Human Gastric Epithelial Cells to Multipotent Endodermal Progenitors using Defined Small Molecules [gene expression] 0.49
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 0.47
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 0.46
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.45
Studying the selectivity of a small molecule Synucleozid on transcriptome 0.45
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.44
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 0.44
HNRNPM-regulated splicing dependencies in prostate cancer 0.44
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.44
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.43
CRISPR/Cas9-mediated ASXL1 mutation in U937 cells perturbs myeloid differentiation 0.4
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 0.4
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 0.39
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 0.39
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 0.38
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.37
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.36
SQSTM1/p62-directed metabolic reprogramming is essential for normal neurodifferentiation 0.34
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.34
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.33
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 0.24
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 0.23
The bromodomain protein BRD4 regulates splicing during heat shock 0.2
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.19
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 0.18
Next Generation Sequencing Study of Circadian Changes in Transcriptome of Human Pineal Gland 0.17
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.16
Oncogenic roles of ARID5B in T-ALL 0.16
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.12
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.09
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 0.05
BMS-470539 on human synovial fibroblasts 0.01
Leucegene: AML sequencing (part 6) 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation